Andean Precious Metals (CVE:APM) Stock Price Down 5.1% - Time to Sell?

Shares of Andean Precious Metals Corp. (CVE:APM - Get Free Report) were down 5.1% during mid-day trading on Friday . The company traded as low as C$1.26 and last traded at C$1.29. Approximately 88,871 shares changed hands during trading, a decline of 54% from the average daily volume of 192,505 shares. The stock had previously closed at C$1.36.

Wall Street Analysts Forecast Growth

Separately, Desjardins raised Andean Precious Metals to a "moderate buy" rating in a report on Thursday, October 31st.

Andean Precious Metals Trading Down 5.1 %

The company has a market capitalization of C$192.67 million, a P/E ratio of 3.39 and a beta of 1.22. The stock has a 50 day moving average of C$1.46 and a 200-day moving average of C$1.25.

Insiders Place Their Bets

In other Andean Precious Metals news, insider 2176423 Ontario Ltd. acquired 84,400 shares of the company's stock in a transaction dated Tuesday, October 8th. The stock was purchased at an average price of C$1.51 per share, with a total value of C$127,359.60. Insiders bought a total of 306,200 shares of company stock worth $432,953 over the last three months. 69.37% of the stock is currently owned by company insiders.

About Andean Precious Metals

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.